Brello Health charges $399 upfront for three months of compounded semaglutide and $499 every 11 weeks for tirzepatide—both prepaid. Here's how those rates compare to month-to-month and flexible-commitment options from PlexusDx and seven verified competitors.

Brello Health advertises compounded semaglutide at $133 per month and tirzepatide at $196 per month, both delivered as prepaid multi-month plans. We compare the upfront commitment, recurring cost structure, and month-to-month alternatives with verified pricing captured September 2026.

Brello Health advertises all-inclusive pricing for compounded GLP-1 medication, but the prepaid structure and renewal timing create cost-transparency questions that matter at the point of decision.

Brello Health charges no membership fee; medication costs $399 for three months of semaglutide or $499 for 11 weeks of tirzepatide, prepaid and all-inclusive. Here's how the upfront pricing compares to month-to-month alternatives.

Brello Health advertises $399 for three months of compounded semaglutide and $499 for tirzepatide, but public sources do not disclose whether those rates change when your dose increases during treatment.

Brello Health requires upfront payment for three-month or eleven-week blocks. We compare the effective monthly cost of Brello's prepaid structure against true month-to-month and subscription options.

Brello Health charges $399 every three months for compounded semaglutide and $499 every eleven weeks for tirzepatide—no separate first-month or refill tiers. We compare those prepaid rates to PlexusDx's month-to-month and commitment pricing over twelve months.

Brello Health's prepaid three-month plans deliver significant savings on compounded semaglutide and tirzepatide injections, but several providers offer month-to-month billing, broader medication options, and comparable or lower annual costs with less upfront commitment.

Brello Health charges $499 upfront for compounded tirzepatide injection, rebilling every 11 weeks with no membership fee. This analysis compares that structure to month-to-month and prepaid alternatives, calculates the true annualized cost, and explains which model suits different budgets.

Brello Health charges $399 upfront for three months of compounded semaglutide and $499 every 11 weeks for tirzepatide. Both medications require prepayment with no separate membership fees.

Brello Health charges $399 upfront for three months of compounded semaglutide; PlexusDx offers $189 month-to-month or $169/month prepaid. We compare both injections, upfront commitments, and 12-month costs.

Switching from Brello Health to PlexusDx requires coordinating your final Brello shipment with your PlexusDx intake approval to avoid a dose gap. This guide walks through timing, cost differences, and clinical handoff steps.

Brello Health charges $399 every three months for compounded semaglutide and $499 every 11 weeks for tirzepatide, both requiring full prepayment. This analysis breaks down the upfront costs, effective monthly rates, and 12-month totals against month-to-month alternatives.

Fifty410 charges $399–$549 upfront for three months of tirzepatide; Brello rebills $499 every 11 weeks. Both require prepayment. We compare effective monthly costs, billing structures, and dose flexibility across both services and PlexusDx's $269/month three-month plan.